ClinicalTrials.govpublic full text
Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants
moderate hepatic impairment, moderate hepatic impaired, healthy subjects, pexidartinib, clinical pharmacology study, tenosynovial giant cell tumor (tgct), interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847594
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.